Literature DB >> 30926290

Faecal microbiota transplantation for the decolonization of antibiotic-resistant bacteria in the gut: a systematic review and meta-analysis.

V Tavoukjian1.   

Abstract

Antibiotic resistance is a growing global problem associated with increased morbidity and mortality, and presents a significant financial and economic burden on healthcare. Faecal microbiota transplantation (FMT) has been proven effective for curing recurrent Clostridium difficile infections, however no systematic review to date has addressed its effectiveness for decolonization of antibiotic-resistant bacteria from the gut. The aim of this study was to establish whether faecal microbiota transplantation decolonizes antibiotic-resistant bacteria from the gut of colonized adults. A systematic review was performed by undertaking a comprehensive search on MEDLINE, Embase, CENTRAL, PubMed and CINAHL databases for evidence up until May 2018. Randomized and non-randomized studies evaluating the effects of FMT on gut colonization of antibiotic-resistant bacteria in adults were eligible. Studies were assessed using the Joanna Briggs Institution critical appraisal checklists. Quality of reporting was assessed using PROCESS and CARE checklists. Data was synthesized narratively, along with a meta-analysis of proportions for the primary outcome. Five studies with a total number of 52 participants were included. Evidence of low quality showed that decolonization was achieved in half of the cases one month after FMT with higher response noted in Pseudomonas aeruginosa, and lower response in Klebsiella pneumoniae with New Delhi metallo-beta-lactamase 1 (NDM-1) and extended-spectrum β-lactamase (ESBL) mechanisms of resistance. In successful cases, 70% of decolonization cases occurred within the first week after FMT. Few temporary adverse events were identified. Despite the limitations of the included studies, evidence from this review indicates a potential benefit of FMT as a decolonization intervention, which can only be confirmed by future well-designed RCTs.
Copyright © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Colonization resistance; Decolonization; Faecal microbiota transplantation; Gut microbiota

Mesh:

Year:  2019        PMID: 30926290     DOI: 10.1016/j.jhin.2019.03.010

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  16 in total

Review 1.  Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia.

Authors:  Armin Rashidi; Daniel J Weisdorf
Journal:  Transl Res       Date:  2020-04-05       Impact factor: 7.012

Review 2.  Orchestrating the fecal microbiota transplantation: Current technological advancements and potential biomedical application.

Authors:  Manisha Nigam; Abhaya Shikhar Panwar; Rahul Kunwar Singh
Journal:  Front Med Technol       Date:  2022-09-22

3.  Gut Microbiota Protected Against pseudomonas aeruginosa Pneumonia via Restoring Treg/Th17 Balance and Metabolism.

Authors:  Long Wen; Lei Shi; Xiang-Long Kong; Ke-Yu Li; Hui Li; Di-Xuan Jiang; Fan Zhang; Zhi-Guo Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

4.  Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease.

Authors:  Masoumeh Azimirad; Abbas Yadegar; Fatemeh Gholami; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Gianluca Ianiro; Hidekazu Suzuki; Giovanni Cammarota; Mohammad Reza Zali
Journal:  J Inflamm Res       Date:  2020-09-18

Review 5.  Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.

Authors:  Monika Maria Biernat; Donata Urbaniak-Kujda; Jarosław Dybko; Katarzyna Kapelko-Słowik; Iwona Prajs; Tomasz Wróbel
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

6.  Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial.

Authors:  Blair Merrick; Emily Robinson; Catey Bunce; Liz Allen; Karen Bisnauthsing; Chi Chi Izundu; Jordana Bell; Gregory Amos; Manu Shankar-Hari; Anna Goodman; Debbie L Shawcross; Simon D Goldenberg
Journal:  BMJ Open       Date:  2020-05-25       Impact factor: 2.692

7.  Prolonged Carriage of Carbapenemase-Producing Enterobacteriaceae: Clinical Risk Factors and the Influence of Carbapenemase and Organism Types.

Authors:  Yong Kyun Kim; In Bok Chang; Han Sung Kim; Wonkeun Song; Seung Soon Lee
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

Review 8.  Immunotherapy and vaccination against infectious diseases.

Authors:  Meinolf Ebbers; Christoph J Hemmer; Brigitte Müller-Hilke; Emil C Reisinger
Journal:  Wien Klin Wochenschr       Date:  2020-12-16       Impact factor: 1.704

9.  Antimicrobial stewardship: a COVID casualty?

Authors:  C Lynch; N Mahida; J Gray
Journal:  J Hosp Infect       Date:  2020-10-09       Impact factor: 3.926

10.  Is there a role of faecal microbiota transplantation in reducing antibiotic resistance burden in gut? A systematic review and Meta-analysis.

Authors:  Priyanga Dharmaratne; Nannur Rahman; Anthony Leung; Margaret Ip
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.